# BLEOMYCIN SULFATE
> **ANDA065033** · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA · Approved 2000-06-27
## Drug
- **FDA Application Number:** ANDA065033
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BLEOMYCIN SULFATE
- **Generic name:** Bleomycin Sulfate
- **Active ingredients:** BLEOMYCIN SULFATE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Discontinued
- **Sponsor:** TEVA PHARMS USA
- **First approval:** 2000-06-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=065033)
---
*AI Analytics · CC0 1.0*